Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus

Physiological Genomics

Volumn 1999, Issue 1, 1999, Pages 41-50

  Davia, Kerry ^a   Hajjar, Roger J ^b   Terracciano, Cesare M N ^a   Kent, Natasha Singh ^a   Ranu, Hardeep K ^a   O'Gara, Peter ^a   Rosenzweig, Anthony ^b   Harding, Sian E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Calcium transient; Cardiomyocyte; Gene transfer; Relaxation; Sarco(endo)plasmic reticulum calcium adenosinetriphosphatase

Indexed keywords

ADENOVIRIDAE;

ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA GALACTOSIDASE; CALCIUM; CALCIUM BINDING PROTEIN; ENZYME INHIBITOR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PHOSPHOLAMBAN; PHOTOPROTEIN; RECOMBINANT DNA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THAPSIGARGIN;

ADENOVIRUS; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HEART CONTRACTION; HEART VENTRICLE; METABOLISM; PHYSIOLOGY; RAT;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CELLS, CULTURED; DNA, RECOMBINANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HEART VENTRICLES; LUMINESCENT PROTEINS; MYOCARDIAL CONTRACTION; RATS; RECOMBINANT FUSION PROTEINS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THAPSIGARGIN; TRANSFECTION;

EID: 0033620974     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.1999.1.2.41     Document Type: Article

References (37)

1. Arai, M., H. Matsui, and M. Periasamy. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ. Res. 74: 555-563, 1994.
2. Balaguru, D., P. S. Haddock, J. L. Puglisi, D. M. Bers, and W. A. Coetzee. Role of sarcoplasmic reticulum in contraction and relaxation of immature rabbit ventricular myocytes. J. Mol. Cell. Cardiol. 29: 2747-2757, 1997.
3. Bartel, S., B. Stein, T. Eschenhagen, U. Mende, J. Neumann, W. Schmitz, E. G. Krause, P. Karczewski, and H. Scholz. Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts. Mol. Cell. Biochem. 157: 171-179, 1996.
4. Bassani, J. W. M., R. A. Bassani, and D. Bers. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J. Physiol. (Lond.) 476: 279-293, 1994.
5. Bohm, M., K La Rosee, U. Schmidt, C. Schulz, R. H. Schwinger, and E. Erdmann. Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure. Clin. Investig. 70: 421-425, 1992.
6. Bohm, M., B. Reiger, R. H. G. Schwinger, and E. Erdmann. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc. Res. 28: 1713-1719, 1994.
7. Chu, G., G. W. Dorn, W. Luo, J. M. Harrer, V. J. Kadambi, R. A. Walsh, and E. G. Kranias. Monomeric phospholamban overexpression in transgenic mouse hearts. Circ. Res. 81: 485-492, 1997.
8. Davia, K., C. H. Davies, and S. E. Harding. Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction of myocytes from failing human ventricle. Cardiovasc. Res. 33: 88-97, 1997.
9. Davies, C. H., K. Davia, J. G. Bennett, J. R. Pepper, P. A. Poole-Wilson, and S. E. Harding. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92: 2540-2549, 1995.
10. Del Monte, F., P. O'Gara, P. A. Poole-Wilson, M. H. Yacoub, and S. E. Harding. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc. Res. 30: 281-290, 1995.
11. Ellingsen, O., A. J. Davidoff, S. K. Prasad, H. J. Berger, J. P. Springhorn, J. D. Marsh, R. A. Kelly, and T. W. Smith. Adult rat ventricular myocytes cultured in defined medium: phenotype and electromechanical function. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H747-H754, 1993.
12. Feldman, A. M., A. E. Cates, W. B. Veazey, R. E. Hershberger, M. R. Bristow, K. L. Baughman, W. A. Baumgartner, and C. Van Dop. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J. Clin. Invest. 82: 189-197, 1988.
13. 2+-ATPaSe and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J. Mol. Med. 74: 321-332, 1996.
14. Ghu, G., W. Luo, J. P. Slack, C. Tilgmann, W. E. Sweet, M. Spindler, K. W. Saupe, G. P. Boivin, C. S. Moravec, I. L. Grupp, and J. S. Ingwall. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ. Res. 79: 1064-1076, 1996.
15. Gwathmey, J. K., L. Copelas, R. MacKinnon, F. J. Schoen, M. D. Feldman, W. Grossman, and J. P. Morgan. Abnormal calcium handling in myocardium from patients with end-stage heart failure. Circ. Res. 61: 70-76, 1987.
16. Hajjar, R. J., J. X. Kang, J. K. Gwathmey, and A. Rosenzweig. Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation 95: 423-429, 1997.
17. Hajjar, R. J., U. Schmidt, J. X. Kang, T. Matsui, and A. Rosenzweig. Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca ATPase. Circ. Res. 81: 145-153, 1997.
18. Hajjar, R. J., U. Schmidt, T. Matsui, J. L. Guerrero, K. Lee, J. K. Gwathmey, G. W. Dec, M. J. Semigran, and A. Rosenzweig. Modulation of ventricular function through gene transfer in vivo. Proc. Natl. Acad. Sci. USA 95: 5251-5256, 1998.
19. Harding, S. E., G. Vescovo, M. Kirby, S. M. Jones, J. Gurden, and P. A. Poole-Wilson. Contractile responses of isolated rat and rabbit myocytes to isoproterenol and calcium. J. Mol. Cell. Cardiol. 20: 635-647, 1988.
20. 2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 75: 434-442, 1994.
21. Koss, K. L., I. L. Grupp, and E. G. Kranias. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Basic Res. Cardiol. 92, Suppl. 1: 17-24, 1997.
22. 2+-ATPaSe in failing and nonfailing human hearts. Cardiovasc. Res. 31: 625-632, 1996.
23. 2+-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ. Res. 69: 1380-1388, 1991.
24. Meyer, M., W. Schillinger, B. Pieske, C. Holubarsch, C. Heilmann, H. Posival, G. Kuwajima, K. Mikoshiba, H. Just, G. Hasenfuss, et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995.
25. 2+ uptake in sarcoplasmic reticulum from normal and failing hearts. J. Clin. Invest. 85: 1698-1702, 1990.
26. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657, 1994.
27. Movsesian, M. A., C. Leveille, J. Krall, J. Colyer, J. H. Wang, and K. P. Campbell. Identification and characterization of proteins in sarcoplasmic reticulum from normal and failing human left ventricles. J. Mol. Cell. Cardiol. 22: 1477-1485, 1990.
28. Mulieri, L. A., G. Hasenfuss, B. J. Leavitt, P. D. Allen, and N. R. Alpert. Altered myocardial force-frequency relation in human heart failure. Circulation 85: 1743-1750, 1992.
29. Puglisi, J. L., R. A. Bassani, J. W. Bassani, J. N. Amin, and D. M. Bers. Temperature and relative contributions of Ca transport systems in cardiac myocyte relaxation. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1772-H1778, 1996.
30. 2+-ATPaSe activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995.
31. Schwinger, R. H. G., M. Bohm, J. Muller-Ehmsen, R. Uhlmann, U. Schmidt, A. Stablein, P. Uberfuhr, E. Kreuzer, B. Reichart, H. Eissner, and E. Erdmann. Effect of inotropic Stimulation on the negative force-frequency relationship in the failing human heart. Circulation 88: 2267-2276, 1993.
32. Tanaka, H., and K. Shiegenobu. Effect of ryanodine on neonatal and adult rat heart: developmental increase in sarcoplasmic reticulum function. J. Mol. Cell. Cardiol. 21: 1305-1313, 1989.
33. 2+ extrusion mechanisms to relaxation in guinea-pig ventricular myocytes. J. Physiol. (Lond.) 500: 557-570, 1997.
34. Vetter, R., M. Kott, W. Schulze, and H. Rupp. Influence of different culture conditions on sarcoplasmic reticular calcium transport in isolated neonatal rat cardiomyocytes. Mol. Cell. Biochem. 188: 177-185, 1998.
35. 2+-exchanger and SERCA2 in rat heart. J. Mol. Cell. Cardiol. 27: 1689-1701, 1995.
36. Von der Leyen, H., U. Mende, W. Meyer, J. Neumann, M. Nose, W. Schmitz, H. Scholz, J. Starbatty, B. Stein, H. Wenzlaff, V. Doring, P. Kalmar, and A. Haverich. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations. Naunyn Schmiedebergs Arch. Pharmacol. 344: 90-100, 1991.
37. 2+. Am. J. Physiol. 271 (Cell Physiol. 40): C391-C397, 1996.